Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Monique Pourtein"'
Autor:
Olivier Thaunat, Françoise Hau, Mathilde Prezelin-Reydit, Isabelle Etienne, Laetitia Albano, Virginie Renac, Valérie Dubois, Cécile Vigneau, Monique Pourtein, Sophie Caillard, A. Parissiadis, Jonathan Visentin, Jean-Luc Taupin, Gwendaline Guidicelli, Lionel Couzi, Christophe Mariat, Benoit Barrou, Lena Absi, Pierre Merville
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, 2021, 10 (9), ⟨10.3390/jcm10092032⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (9), ⟨10.3390/jcm10092032⟩
Volume 10
Issue 9
Journal of Clinical Medicine, Vol 10, Iss 2032, p 2032 (2021)
Journal of Clinical Medicine, 2021, 10 (9), ⟨10.3390/jcm10092032⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (9), ⟨10.3390/jcm10092032⟩
Volume 10
Issue 9
Journal of Clinical Medicine, Vol 10, Iss 2032, p 2032 (2021)
Background: Non-adherence with immunosuppressant medication (MNA) fosters development of de novo donor-specific antibodies (dnDSA), rejection, and graft failure (GF) in kidney transplant recipients (KTRs). However, there is no simple tool to assess M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4439dbd8f15746760f91e3c9418331
https://hal.science/hal-03245035/file/jcm-10-02032.pdf
https://hal.science/hal-03245035/file/jcm-10-02032.pdf
Autor:
Jacques Chiaroni, Christophe Picard, Monique Pourtein, Sandra Grondin, Laurène Budon, Gérard Michel, Sophie Simon, Pascal Pedini, Agnès Basire, Coralie Frassati, Philippe Moskovtchenko, Nicem Cherouat
Publikováno v:
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 2020, ⟨10.1016/j.bbmt.2020.09.023⟩
Biology of Blood and Marrow Transplantation, Elsevier, 2020, ⟨10.1016/j.bbmt.2020.09.023⟩
Transplantation and Cellular Therapy
Transplantation and Cellular Therapy, 2021, 27 (1), pp.89.e1-89.e10. ⟨10.1016/j.bbmt.2020.09.023⟩
Biology of Blood and Marrow Transplantation, 2020, ⟨10.1016/j.bbmt.2020.09.023⟩
Biology of Blood and Marrow Transplantation, Elsevier, 2020, ⟨10.1016/j.bbmt.2020.09.023⟩
Transplantation and Cellular Therapy
Transplantation and Cellular Therapy, 2021, 27 (1), pp.89.e1-89.e10. ⟨10.1016/j.bbmt.2020.09.023⟩
International audience; Hematopoietic stem cell transplantation (HSCT) is a curative treatment for most hematologic diseases. To evaluate the level of donor engraftment, chimerism must be carefully monitored after HSCT. Short tandem repeats, quantita
Publikováno v:
Journal of Vascular Surgery. 67:680-681
Autor:
John Widjenes, Isabelle Alberti, Alain Bernard, Monique Pourtein, Vincent Raimondi, Michel Ticchioni, Ghislaine Bernard
Publikováno v:
European Journal of Immunology. 30:3061-3065
CD99/E2 is an integral transmembrane protein which forms, together with Xga, a distinct family whose genes are located in the pseudoautosomal region. The number of T cells that firmly bound to vascular endothelial cells under physiological shear stre
Autor:
Philippe Vincendeau, Valérie de Précigout, Luc Potaux, Delphine Morel, Jean Henri Bézian, Monique Pourtein, Michel Aparicio, Christian Combe, Annie Baquey
Publikováno v:
Scopus-Elsevier
Hemodialysis with complement-activating membranes, such as cuprophane, induces neutropenia and expression of the granulocyte adhesion receptor Mac-1 (CD11b/CD18), while hemodialysis with noncomplement-activating membranes does not. Increased expressi
Autor:
Monique Pourtein, Alain Bernard, Isabelle Alberti, Ghislaine Bernard, Claudette Pelassy, Alexandre K. Rouquette-Jazdanian, Claude Aussel
Publikováno v:
The FASEB Journal. 16:1946-1948
CD99, a unique integral membrane protein present on the surface of all human T cells, has previously been shown to regulate cell function and fate. In peripheral T cells, it triggers immediate activation of alpha4b1 integrin and cell arrest on inflam
Autor:
Mette Kløvstad Olafsen, Monique Pourtein, Ghislaine Bernard, Sverre O. Lie, Rolf D. Pettersen
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 166(8)
Death signaling by Fas and TNF receptors plays a major role in the control of activated mature T cells. However, the nature of the death receptors, which may be used by the immune system to control T cells that have not acquired susceptibility to Fas